65 results found.
      
Integra LifeSciences 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates Integra LifeSciences’ 2Q17 orthopaedic revenue at US $37.3MM, +34.1% from 2Q16, and 1H17 revenue of
Integra Posts 1Q17 Revenue
ORTHOWORLD estimates Integra LifeSciences’ 1Q17 orthopaedic revenue at US $31.2MM, +19.6% from 1Q16.
Wright Medical Company Profile
We're redesigning Company Profiles. To get the most current news and articles about Wright Medical in the interim, pl...
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
Integra LifeSciences Posts 4Q16 and 2016 Revenue
ORTHOWORLD estimates Integra LifeSciences’ 2016 orthopaedic revenue at US $108.3MM, +20.8% from 2015, with 4Q16 revenue of
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Wright Medical Reports 3Q16 Revenue
Wright Medical reported 3Q16 revenue of US $157.3MM, +8.7% from 3Q15. (U.S. $118.1MM, +11.1%; ex-U.S. $39.3MM, +2.0%
Integra LifeSciences Reports 3Q16 Revenue
ORTHOWORLD estimates Integra LifeSciences' 3Q16 orthopaedic revenue at US $27.7MM, +15.4% from 3Q15.
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
SeaSpine Reports 2Q16 Revenue
SeaSpine announced 2Q16 revenue of US $33.2MM, -0.8% vs. 2Q15. Growth is as reported.
Integra LifeSciences Reports 2Q16 Revenue
ORTHOWORLD estimates Integra LifeSciences 2Q16 orthopaedic revenue of US $27.8MM, +39.1% from 2Q15, as reported.
Integra Reports 1Q16 Revenue
ORTHOWORLD estimates Integra LifeSciences 1Q16 orthopaedic revenue of US $26.1MM, +37.9% vs. 1Q15 as-reported.
Integra LifeSciences Reports 4Q15/2015 Orthopedics & Tissue Technologies Revenue
Integra LifeSciences posted 4Q15 Orthopedics and Tissue Technologies revenue of US $88.0MM, +32.6%
Company Revenue 2015: Integra LifeSciences
2015: $89.6MM, +23% 4Q15: $26.7MM, +34.3% ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows. Joint Reconstruction $17.8MM, +22.3% Trauma $71.9MM, +23.8%   Notes overall revenue headwind...
Integra LifeSciences Posts 3Q15 Revenue
Integra LifeSciences posted 3Q15 Orthopedics and Tissue Technologies revenue of US $79.2MM, +32% vs. 3Q14.
BARE BONES® - July 30, 2015
Integra LifeSciences reported 2Q15 Orthopedics & Tissue Technologies revenue of US $63.8MM, +10% vs. 2Q14. (
BARE BONES® - April 30, 2015
Integra LifeSciences reported 1Q15 Orthopedics & Tissue Technologies revenue of US $61.3MM, +12%, and Spine revenue of $32.2MM, -3% vs. 1Q14. (
BARE BONES® - February 24, 2015
Integra LifeSciences reported 2014 orthopaedic revenue of US $370.0MM, flat vs. 2013. (U.S. Extremities $143.3MM, +11.7%; U.S. Spine & Other $171.3MM, -5.8%) (Segment growth reflects constant currency.) (
2014 Revenue: Integra LifeSciences
4Q14 revenue: $98.1MM, flat (U.S. $83.4MM, +2%; ex-U.S. $14.7MM, -13%) U.S. Extremities $40.3MM, +17% U.S. Spine & Other $43.1MM, -8%   New product introductions (Titan Shoulder, Total Foot System 2, Freedom Wrist) + ad...
BARE BONES® - November 3, 2014
Integra LifeSciences reported 3Q14 orthopaedic revenue of ~US $78.7MM, -10.6% from 3Q13. (U.S. Extremities $36.7MM, +15%, U.S. Spine & Other $42.0MM, -11%) (
3Q14 Revenue: Integra LifeSciences
$91.6MM, -7% (U.S. $78.6MM, -4%; ex-U.S. $12.9MM, -23%) U.S. Extremities $36.7MM, +15% U.S. Spine & Other $42.0MM, -11% (Spine -3%, Private Label +26%)   Strong growth from Total Foot System and shoulder launch, Premier...
BARE BONES® - August 5, 2014
Integra LifeSciences reported 2Q14 orthopaedic revenue of US $79.5MM, +5% from 2Q13. (U.S. Extremities $43.4MM, +8%, U.S. Spine & Other $45.0MM, +4%) (
2Q14 Revenue: Integra LifeSciences
Orthopaedic revenue $79.5MM, +5% U.S. Extremities $43.4MM, +8% (includes skin and wound repair products) U.S. Spine & Other $45.0MM, +4% (U.S. Spine flat; Private Label $14.1MM)   Growth buoyed by shoulder product launc...
BARE BONES® - May 1, 2014
Integra LifeSciences reported 1Q14 orthopaedic revenue of US $72.9MM, -2.5% from 1Q13. (U.S. Extremities $31.9MM, +2%, U.S. Spine & Other $41.0MM, -6%) (
1Q14 Revenue: Integra LifeSciences
$72.9MM, -3% U.S. Extremities $31.9MM, +2% U.S. Spine & Other $41.0MM, -6% (U.S. Spine -7%)   Extremities impacted somewhat by weather U.S. Spine decline entirely in hardware; biologics grew in mid-single...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group